Peer-influenced content. Sources you trust. No registration required. This is HCN.

CephalalgiaTwo Hundred and Forty-Eight Cases of Visual Snow: A Review of Potential Inciting Events and Contributing Comorbidities

Post-concussion, infection, migraine change, and hallucinogen use drove 42% of VS cases; secondary cases showed significantly greater improvement at follow-up (p <.001).

🔬 Clinical Considerations

  • 42% of VS cases had identifiable triggers: post-concussion (15), dramatic migraine/aura change (14), post-infection (13), and HPPD (10) led secondary causes; secondary cases improved at 3x the rate of spontaneous cases (30.3% vs. 8.3%)
  • Treatable underlying causes include IIH, ocular pathology, neoplasm, and MS: two patients had demyelinating disease; four had IIH; one resolved after temporal lobe tumor resection and radiation
  • No medication provided complete remission; partial response rates: lamotrigine 17%, topiramate 6%, benzodiazepines highest responder rate, acetazolamide 21% in IIH-associated cases
  • Anxiety was significantly more prevalent in primary VS (58% vs. 36%, p=.002), while palinopsia and floaters also tracked with spontaneous onset

🎯 Practice Applications

  • Obtain brain MRI with gadolinium, ophthalmologic exam, and funduscopy for papilledema in all new-onset VS presentations
  • Screen for IIH by history (transient visual obscurations, whooshing tinnitus) before attributing VS to primary etiology
  • Counsel patients with identifiable triggers that partial improvement is possible, particularly when the underlying cause is addressable
  • Consider EEG when VS onset coincides with suspected seizure activity or features of neurodegeneration

More in Migraines/Headaches

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form